Inhibition of the renin–angiotensin system and target organ protection
- 27 February 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Hypertension Research
- Vol. 32 (4), 229-237
- https://doi.org/10.1038/hr.2009.5
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Telmisartan prevented cognitive decline partly due to PPAR-γ activationBiochemical and Biophysical Research Communications, 2008
- Angiotensin II Blockade and Aortic-Root Dilation in Marfan's SyndromeNew England Journal of Medicine, 2008
- Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone ratsMicrovascular Research, 2007
- Angiotensin II type 1 receptor blockade attenuates TGF-β–induced failure of muscle regeneration in multiple myopathic statesNature Medicine, 2007
- Isolation and identification of proangiotensin-12, a possible component of the renin–angiotensin systemBiochemical and Biophysical Research Communications, 2006
- Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significanceOncogene, 2006
- Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosisBiochemical and Biophysical Research Communications, 2006
- Cooperative Regulation of Extracellular Signal-Regulated Kinase Activation and Cell Shape Change by Filamin A and β-ArrestinsMolecular and Cellular Biology, 2006
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006
- ATRAP, Novel AT1 Receptor Associated Protein, Enhances Internalization of AT1 Receptor and Inhibits Vascular Smooth Muscle Cell GrowthBiochemical and Biophysical Research Communications, 2000